Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products…

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for…

Make your ideas reality with the SNSF   The Swiss National Science Foundation (SNSF) recently opened applications for its “project…

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841…

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs…

GeNeuro received CHF 6.7 million in funding for the development of temelimab against Long-COVID   GeNeuro, a biopharmaceutical company developing…

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the…

In November 2021, Intellias, a technology partner of Fortune 500 companies and top-tier organizations, and D36.ch, an innovative Swiss healthcare startup, announced their strategic partnership. The companies are joining efforts to build a bridge between the Swiss digital health market and world-class IT services to reinforce customers’ digital strength by combining 360-degree domain expertise with state-of-the-art software engineering solutions.

Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private…

1st establishment of a US company in Western Switzerland without prior in-person meeting   A first for the canton of…

Medical innovation & contribution to the future of medicine   On 30 November, 2021, Mrs Annick Chevillot (Heidi.news) has moderated…

Underlines the ambition of the HEIG-VD to pursue its development in management applied to the health sector, both in the field of education and research

Deep Bio and HealthCare Konnect (HCK) partner to improve cancer diagnosis in Switzerland and North Africa   On 18 October…

Investing, innovating and hiring in Switzerland to prevent infection worldwide   We are pleased to share with you our new…

Debiopharm | We develop for patients   We are pleased to share with you our new testimonial series as part…

Developing first-in-class bi-/trispecific antibodies to treat cancer patients   We are pleased to share with you our new testimonial series…

Switzerland establishes a national infrastructure to track COVID-19 and its variants Discover the role of the Swiss Pathogen Surveillance Platform…

Developing and distributing efficacious natural healthcare products   We are pleased to share with you our new testimonial series as…

Fast-tracking innovation through long-term mutual partnerships with academia   We are pleased to share with you our new testimonial series…

On a mission to help patients live better, healthier lives   We are pleased to share with you our new…

Strengthening the Life Sciences value chain from discovery to market   We are pleased to share with you our new…

Supporting the Swiss economy with locally rooted training and applied research   We are pleased to share with you our…

Selexis | Cell line development meets lab automation and robotics for biologic therapeutic manufacturing   We are pleased to share…

Fongit | Switzerland’s premier startup incubator   We are pleased to share with you our new testimonial series as part…

SILAB ǀ Dedicated to promoting a relevant and sustainable innovation in healthcare   We are pleased to share with you…

UNIL | A commitment to transforming Life Sciences into concrete actions for the benefit of all   We are pleased…

CERN | Unique technologies with a wide scope of applications   We are pleased to share with you our new…

Netsensing | Saving lives through the detection of sleep apnea   We are pleased to share with you our new…

JAG | Highly automated process plants for the pharmaceutical and biotech industries   We are pleased to share with you…

GGBa | The official investment promotion agency for Western Switzerland   We are pleased to share with you our new…

Gnubiotics | Novel microbiome health solutions   We are pleased to share with you our new testimonial series as part…

Fighting against neurodegenerative and autoimmune disease with antibodies   We are pleased to share with you our new testimonial series…

Minibrain technology enabling efficient drug testing and development   We are pleased to share with you our new testimonial series…

Thin-film encapsulation technology helping increase product reliability and miniaturisation effectiveness   We are pleased to share with you our new…

UCB | Creating value for patients now and into the future   We are pleased to share with you our…

A necessity for scientific progress   Despite the many advancements in developing innovative alternative methods, animal testing still plays an…

SBA | Representing the interests of the Swiss biotech industry   We are pleased to share with you our new…

60 years of high-quality manufacturing of liquid handling instruments   We are pleased to share with you our new testimonial…

Key medtech player fostering innovative medical software solutions and device development projects   We are pleased to share with you…

High-quality support and valuable community for life sciences companies   We are pleased to share with you our new testimonial…

Intellectual property for Life Sciences innovators   We are pleased to share with you our new testimonial series as part…

Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud   On 31 August 2021, Incyte, the US-based…

Supporting the Life Sciences industry with cell-tech, biomonitoring and lab automation know-how   We are pleased to share with you…

iOnctura | Better drugs to beat cancer resistance   We are pleased to share with you our new testimonial series…

Combioxin has signed a worldwide licensing agreement with Eagle Pharmaceuticals Eagle Pharmaceuticals has entered into a worldwide licensing agreement with…

Addressing the slow pandemic of neurodegenerative diseases   We are pleased to share with you our new testimonial series as…

Connecting tech-oriented companies | Supporting cross-cutting innovation   We are pleased to share with you our new testimonial series as…

Life Sciences innovation initiator | Transforming ideas & research into startups   We are pleased to share with you our…

SIB | Supporting the Life Sciences community with Computational Biology and Bioinformatics know-how   We are pleased to share with…

Nanotechnology to detect sepsis in 5 minutes from one drop of blood   We are pleased to share with you…

Microtech tools meet novel integrated in vitro cellular model to help accelerate research    We are pleased to share with…

Lunaphore was selected as one of the top 10 spatial biology companies in the world   Lunaphore Technologies has been…

FIF | FONGIT Innovation Fund Following the announcement of the creation of the FONGIT Innovation Fund (FIF), the foundation supporting…

CHUV performed the world’s first hybrid robotic general surgery   Distalmotion & CHUV announced the successful start to a case series…

First patient enrollment   EBAMed announced first patient enrolled in prospective imaging study with ultrasound guidance prototype in ventricular tachycardia…

Closing of $234 mio. Initial Public Offering & $20 mio. Private Placement   SOPHiA GENETICS SA (Nasdaq: SOPH), the creator…

CHUV | Biomarkers which could save lives   Scientists at CHUV have identified cells which create metastasis in a tumour….

Merck reaches key milestone in the construction of its Biotech Development Center Announced in January 2020, Merck‘s new state-of-the-art biotech development…

Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases

Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued…

Interview with Andreas Schläpfer, CEO & cofounder   AC BioScience, the Vaud based company is a pioneer in the development…

Scientists at EPFL (Polymers Laboratory) and the University of Warwick have used a virus to identify a peptide that can…

Tissue grows back once the implant is gone   EPFL engineers have developed a neural interface that disappears harmlessly in…

Digital support to Gait Up    CSEM posted a solid financial performance in 2020 and made further progress on important technological…

CHF 50 million for diabetes ventures Launch of the first venture fund dedicated to diabetes technology, through a collaboration between…

Decoding the activation mechanism of the CCR5 receptor By studying the structure of cellular receptors and of the molecules that…

Stimulation of the nervous system with neurotechnology EPFL scientists in a European collaboration propose a personalised protocol for optimising stimulation…

High-energy electron beams can be focused onto deep-seated cancerous tumours   The study, conducted at CERN’s CLEAR test facility, demonstrates…

New office with 60 employees   In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another…

This article was written by Labiotech.eu with the support of BioAlps, the Greater Zurich Area, and Switzerland Global Enterprise (S-GE)….

CHF 1.4 mio for biomedical research in the Lake Geneva region   The Leenaards Foundation has awarded Science Prizes to…

  HEIG-VD is joining forces with the EPFL and the University of Geneva (UNIGE) to take up the challenge of…

The most important prize for young entrepreneurs in Switzerland   From dozens of applications, nine companies were nominated for the…

The first two beneficiaries of the FIF   The foundation supporting technological entrepreneurship in the canton of Geneva, FONGIT, announces…

Ethical & legal questions   Digital twins – a savvy combination of artificial intelligence and personal data – have already…

Meet the Swiss national MedTech team   The Swiss National Startup Team has 10 new members: 10 startups were selected…

Sum used to develop targeted antibodies for cancer patients   Abologix develops a new therapeutic option to treat lymphoma patients…

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited…

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour…

Welcome to new activity report of the SIB Swiss Institute of Bioinformatics, the nationwide organisation dedicated to biological and biomedical…

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva…

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million…

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that…

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research…

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date…

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific…

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT)…

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes…

A novel algorithmic approach on cancer cells   Scientists at EPFL and UNIL have used a novel algorithmic approach on…

CHF 5 million fundraising bNovate Technologies SA, a Swiss company specialised in industrial microbiology aiming at increasing the safety of…

Prize of CHF 50’000   EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The scientists…

Significant investments to expand its mammalian drug substance manufacturing facilities in Visp The Lonza‘s expansion in Visp (Valais, Switzerland) will…

Strategic collaboration agreement between Swiss Biotech Center & Berna Biotech Pharma The Swiss biotech companies Berna Biotech Pharma Gmbh and…

CHF 150,000 for RNA sequencing to boost biomedical research Lausanne-based Alithea Genomics, developing a novel technology that enables a high…

The Lemanic region as a hub for Life Science innovation   Debiopharm a Swiss biopharmaceutical company based in Lausanne, announced the…

Commercialisation of the T50 Test to drive more efficient therapies for renal patients    Calciscon AG announced  the closing for…

Building clinical research momentum with 500’000 CHF Tech Growth loan Clinical research and studies demonstrate Gondola Medical Technologies AMPS therapy’s…

Awakening “ghosts” in patients with Parkinson’s   EPFL scientists are developing a completely new “brain stress test” for evaluating the…

Introduction of AI suite in Swiss medical institutions   South Korean Medical AI trailblazer, VUNO, and Swiss medical distribution company,…

3 Biopôle-based companies are striving to find innovation solutions   CHUV-NeuroTech, ND BioSciences & Gondola Medical Technologies , 3 Biopôle-based companies are…

Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method   CoreMedica Europe a Swiss biotechnology company based…

A brand new tool is available to map the organisational impacts    Innovation in health care is shaking up and…

FDA Approval of ZYNLONTA™ in Relapsed or Refractory Diffuse Large B-Cell Lymphoma   ADC Therapeutics SA announced that the Food…

An attractive, dynamic & ever-growing life sciences ecosystem   Biotechnology companies based in Switzerland have experienced record investments in the…

An injectable gel that can attach to various kinds of soft internal tissues    EPFL scientists have developed an injectable…

A new hub for biologics R&D in Western Switzerland   On 1 April 2021, the research-driven biopharmaceutical group Ferring Pharmaceuticals…

In 2020, 85 new foreign companies set up shop in Western Switzerland, supported by Greater Geneva Bern area (GGBa) and the…

Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been…

Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.

Gait Up & Definition12 win the 2020 CSEM digital journey award   CSEM has announced the two winners of its…

Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub  Over the past weeks and with the threat of emerging…

Artificial Brain Intelligence (ABI)   An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud…

The EU consortium will reinforce its penetration to global market & its position with EU partners   Incubated at Microcity,…

CHF 1.5M of non-dilutive funding   Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer,…

ImageBAT   Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK,  the Geneva…

Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds   DeepChest…

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021

In honor of Women’s International Day, EPFL Innovation Park is announcing the launch of Tech4Eva, the first Femtech accelerator in Switzerland,…

The centre will open by the end of the 2nd quarter of 2021   Superlab Suisse AG, a Zurich-based private…

New CEO   EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist…

Life Sciences cluster   The Biopôle site continues its strong development with the construction of three new buildings. By 2024,…

Close collaboration between biopharmaceutical companies & Canton de Neuchâtel   The Canton of Neuchâtel will open up a new dual-mode training route…

A new platform in the field of Artificial Intelligence in medicine   The University of Bern & the Inselspital, Bern…

Newly founded: MCIDI   The University of Bern established a multidisciplinary center to study the origin and course of infectious…

Switzerland is the Mecca of the pharmaceutical industry   ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages…

Dexter surgical robot  Distalmotion, a Swiss-based medical device company establishing a new global standard of care ensuring every patient can…

Antiviral Alisporivir: a valuable additional therapy to SOC   Debiopharm, a Swiss biopharmaceutical company, announced the first patient dosed in…

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…

Eyeware has just entered into a partnership with the company Studio Uni    The startup Eyeware, hosted at IdeArk in…

Netsensing Technology secures a seed financing round to accelerate Home Sleep Apnea Test device development   Netsensing Technology Sàrl has…

A new scientific communication platform   A new scientific communication platform entitled “Connect People with Science” is being launched. Its…

Geneva: 250 new highly technical jobs   JSR Life Sciences, LLC announced that it is increasing its European footprint with…

Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and…

Next generation microfluidic devices for applications in molecular diagnostics   The following article is part of BioAlps’ testimonial series and…

Revolution in Healthcare | How robotics, virtual reality and artificial intelligence are improving the profession   Bilan, in partnership with…

Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments   The following article is part of BioAlps’…

To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern   The new…

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series…

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader…

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial…

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections  …

Leveraging CERN’s novel technologies and know-how to develop health applications   The following article is part of BioAlps’ testimonial series…

SwissCovid app | Privacy by design   The following article is part of BioAlps’ testimonial series and was written by…

Reorganisation of teams and work streams to ensure the production and delivery of life-saving products while protecting the health of…

Digital solutions, fundamental and clinical research, and organisational process redesign to support the fight against COVID and enhance the physicians-patients…

Development of vaccine, drugs and robotic disinfection equipment to fight COVID-19   The following article is part of BioAlps’ testimonial…

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad…

Swiss-made protective visor and door opening device to protect against COVID-19   The following article is part of BioAlps’ testimonial…

Open-access adjuvants and vaccine formulation expertise to benefit the whole community in the fight against COVID-19   The following article…

Fluid and surface disinfection sustainable modular solutions to fight against COVID-19   The following article is part of BioAlps’ testimonial…

Supporting patients, healthcare providers and communities worldwide through treatment and vaccine research, testing resources and donations   The following article…

A Swiss in vitro drug testing platform for the identification of potential treatments against coronavirus   The following article is…

Development of mRNA and DNA vaccines against COVID-19   The following article is part of BioAlps’ testimonial series and was…

High-quality 3D scanning, modelling, and printing solutions for healthcare providers   The following article is part of BioAlps’ testimonial series…

Swiss manufacturer of liquid valves, syringe pumps and mass flow controllers supporting the high-level of demand in ventilators   The…

First-in-class life-saving drugs for severe infections   The following article is part of BioAlps’ testimonial series and was written by…

Marketing and distribution of a wide range of molecular controls and panels   The following article is part of BioAlps’…

How AI can support research by extracting, analysing and compiling data The following article is part of BioAlps’ testimonial series…

How AI applied to cough recordings can help in the identification of COVID-19 cases   The following article is part…

From spirit production to hand sanitisers   The following article is part of BioAlps’ testimonial series and was written by…

Adapting to become a satellite laboratory to carry out genetic testing of SARS-Cov-2 for the Fribourg Hospital (HFR)   The…

From exhaust gas cleaning system to easy-to-assemble face shield against COVID-19   The following article is part of BioAlps’ testimonial…

E4S’ Testimonial | A policy approach to fighting COVID-19   The following article is part of BioAlps’ testimonial series and…

A rapid sepsis test, the key to saving lives   The following article is part of BioAlps’ testimonial series and…

Secure, privacy-conscious data analytics among hospitals   The following article is part of BioAlps’ testimonial series and was written by…

Patients with sleep apnea are more at risk when infected with COVID-19   The following article is part of BioAlps’…

Bioinformatics, a crucial key to a rapid response to the COVID-19 threat   The following article is part of BioAlps’…

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by…

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA…

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the…

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new…

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and…

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based…

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics…

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a…

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University…

CoreMedica Laboratories Inc. provides COVID-19 serology confirmations via a secondary antibody detection method   On 12 June 2020, CoreMedica Laboratories,…

HMCare will launch the production of its HelloMask as of early 2021   For the past two years, the EPFL…

GliaPharm reaches a total of CHF 2 million raised to further its drug development   On 25 May 2020, EPFL…

Bachem supplies key anaesthetic drug to support fight against COVID-19   The Swiss-based company, Bachem, is the world leader in…

BioAlps Networking Day 2020 | Annual gathering of Western Switzerland’s Life Sciences’ Community   The event is planned to take…

Abionic’s sepsis test supports the fight against COVID-19   When the pandemic hit, Abionic was finalising a financing round to…

Lonza | A key player in the COVID-19 vaccine production   Lonza, the Valais-based company, has signed a 10 year…

SNF NRP78 « Covid-19 » Call | Collaboration opportunity with SILAB   SILAB can be a real asset to develop…

ADC Therapeutics chooses the New York Stock Exchange   On 15 May 2020, the Biopôle-based company, ADC Therapeutics went public….

AquaNetto enables you to wear the same mask for an extended period of time   Based in the canton of…

Partners are taking Jakafi drug into a second late-stage trial for COVID-19 patients on ventilators   On 5 May 2020,…

In light of the COVID-19 situation, we are exceptionally posting information in French on our website. Do not hesitate to…

HUG | Preventive treatment for people in contact with COVID-19 patients   The HUG launch a clinical trial called CoPEP…

Avenue de Sécheron, 15

Medtronic is publicly sharing design specifications for its ventilators to support the fight against COVID-19   Medtronic is sharing the…

Adamant Innotech and CSEM develop a simultaneous diagnostic test for past COVID-19, flu and SRAS infections   On 9 April…

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development   Vaud-based Quotient Limited announced on 6 April 20202,…

First rapid COVID-19 serological test to enter Swiss market   On 6 April 2020, Augurix SA and GaDia announce the…

Gnubiotics accelerates testing of multivalent-glycan based pipeline candidates against viral entry of COVID-19   Since 2016, Gnubiotics has invested in…

In light of the COVID-19 situation, we are exceptionally posting the information in French on our website. Do not hesitate…

Aktiia raises new funds to finalise last steps towards market entry   Neuchâtel-based Aktiia, created in 2018, has developed a…

European Commission seeks to delay the new EU Medical Devices Regulation (MDR)   Stella Kyriakides, the European Commissioner for Health…

Swiss Medtech companies defined as part of Switzerland’s critical infrastructure   The Federal Department of Defence, Civil Protection and Sport…

Rheon Medical to launch its eyeWatch product on the Swiss and EU markets   The Vaud-based startup, Rheon Medical, specialised…

1Drop brings medical diagnostics to space   The Neuchâtel-based company, 1Drop Diagnostics, which specialises in the detection of cardiovascular biomarkers…

Teams from UNIFR & SICHH discover a new Alzheimer diagnosis solution based on saliva analysis   The University of Fribourg…

Abionic’s R&D focuses on the development of an early sepsis diagnosis solution | A tool for Coronavirus identification   Abionic,…

EBAMed joins the Mayo Clinic Business Accelerator and starts pre-clinical testing   EBAMed SA, a medical technology company enabling access…

Los Angeles – Geneva – Monthey: CSG-BIO SA (CSG-Bio), which intends to offer the most advanced and comprehensive stem cell banking services to families worldwide in the near future, took over some of CryoSave AG’s assets in 2019. It has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, to secure the hundreds of thousands of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.

New appointment at SOPHiA GENETICS to accelerate the execution of its Medical Strategy   On 13 February 2020, SOPHiA GENETICS, leader…

Lunaphore closes its Series C funding   On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the…

New centre of excellence in the canton of Vaud | GE Healthcare Life Sciences   GE Healthcare Life Sciences will…

Creation of a European Consortium | ORGANTRANS   On 4 February 2020, the CSEM announced the creation of  the European project ORGANTRANS….

The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors   The 8th…

European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups   The European Commission selected 75 startups…

GeNeuro secures investment to further clinical trials   GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing…

Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome   In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects.  …

Merck Biotech Development Center | New Facility in Switzerland   On 27 January 2020, Merck announced a €250 million investment…

Another milestone for Nanolive, as the company moves to new offices   In 2013, Nanolive started its adventure in a…

Abionic to commercialise its rapid sepsis diagnosis product on the EU and US markets   The Abionic team, who has…

Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow   Innovation…

qmt | The industry’s quality test and control reference   On 9 January 2020, SAPHIR and Qualimatest announced that their…

Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria. The partnership aims to introduce vanguard AI diagnostic capabilities and improve detection of 75 pathologies, including tuberculosis, to one of the largest markets in Africa.

Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and patients

BioAlps Networking Day 2019 | Discover key speaker interviews by GGBa   The Greater Geneva Bern area (GGBa) collaborated with BioAlps once…

NeuroRestore Center | A new partnership to restore neurological functions through research, innovation and treatment   Defitech Foundation is partnering with…

Rue du Centre 172

Brain-Computer Interface Technologies | Accelerating Neuro-Technology for Human Benefit The BioAlps team is proud to present our President’s new book….

Smart Protein Project | In search of a meat substitute   HES-SO Valais was selected to take part in the Smart…

Fondée en 2004, POSITIVE COATING se distingue par le développement de solutions innovantes dans le domaine des traitements de surfaces basés sur les technologies PVD (Physical Vapor Deposition) et ALD (Atomic Layer Deposition), des traitements physiques et chimiques de pointe. A l’occasion de son 15-ème anniversaire, elle revient sur les grandes étapes de son parcours et donne la parole à sa direction afin qu’elle nous explique l’origine de son nom et les valeurs de l’entreprise qui ont été moteur de son succès.

Marc Thurner, founder of regenHU, Vivos Dental and mimix biotherapeutics joins Microcity as Stratup Program Manager   In October 2019,…

The rise of Life Sciences in the past 20 years by Entreprise Romande Everything you need to know   Discover…

How will the future of healthcare professions be affected by new technologies?   Agefi’s article provides insider knowledge regarding the…

“The EPFL spin-off GTX Medical moves into the US market”   The Health Valley based startup, GTX Medical, which developed…

A new Chief Marketing Officer and a new Chief Information Officer have joined SOPHiA GENETICS’ Executive Team SOPHiA GENETICS, leader in…

EPFL scientists have discovered the path used by breast cancer cells to metastasize to the brain   One of the…

Fresenius Kabi expands biosimilar research activities – Inauguration of state-of-the-art R&D center in Eysins, Switzerland   On 18 September 2019,…

Virdis Group announces new office opening in Lausanne, Switzerland to further Swiss expansion.

LA JOLLA, California, (Aug 29, 2019) – CureMetrix® a healthcare technology company that develops computer-aided detection (CAD) artificial intelligence (AI) based radiology software, announced that it entered into an agreement with HealthCare Konnect, to bring CureMetrix AI technologies to healthcare institutions in Nigeria and Algeria. The organizations will collaborate to support the clinical advancement of AI technologies to improve breast cancer detection in these regions.

A new Master of Medicine was launched this autumn at Fribourg University, designed in collaboration with the Fribourg Hospital (HFR)…

International pivotal study successfully demonstrates Abionic’s diagnosis of sepsis within 5 minutes – 24 hours earlier compared with current standard-of-care…

EPFL scientists are using AI to improve control over robotic hand use for amputees   Artificial Intelligence (AI) is used…

This year, HUG have implemented Watson for Genomics: the search engine based on tumour genetic information   Watson for Genomics…

Abionic and Genentech have signed an agreement to develop and provide rapid Point-of-Care tests for Asthma in the US  …

Funding supports development of first integrated heart motion management
system and pre-clinical testing

A minuscule needle synonymous of hope for 16 million patients   FEMTOprint has developed, in partnership with the EPFL and…

ADC Therapeutics and SOPHiA GENETICS Partner in Pivotal Phase II Clinical Trial   Study to identify genomic markers associated with…

HUG‘s Experimental Cell Therapy Lab has developed a stem cell based magical healing sponge   The bioabsorbable sponge has proven…

CHUV Professor Solange Peters & team were granted this year’s GO2 Foundation prize   This year’s Bonnie J. Addario prize…

Pharma products take first place on the Swiss export board   The high demande from international markets drives Swiss pharma…

The innovative RWD eConsent solution is ideal for enhancing clinical trials with Real-World Data (RWD), achieving privacy compliance and improving patients’ engagement.

Switzerland, Morges, 12 June 2019 – Pryv, the leading Swiss provider of privacy and personal data management software, and BGO Software, a Bulgaria-based leading software services and product development company, have announced the launch of an innovative eCRF solution to manage Real-World Data (RWD) and informed electronic consent (eConsent).

Professor Cem Gabay has been appointed as the new Dean of the Faculty of Medicine (UNIGE) and Head of the…

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform   Boehringer Ingelheim announced…

Introducing the SBRA “smart bra” project   The SBra project aims to develop an intelligent bra, equipped with sensors, capable…

Troy Cox joins SOPHiA GENETICS as the company expands its decentralized approach to Data-Driven Medicine to foster a sustainable and…

Medicines made of solid gold to help the immune system   By studying the effects of gold nanoparticles on the…

UNIGE and Franche-Comté University researchers have co-developped an innovative device enabling platelet capacity detection   This tool investigates a patient’s…

The appointment of the new rectorate of UNIGE by the Council of State was revealed on Thursday 20 June 2019.   Prof….

Dr Mary Tolikas has been appointed as the new Director of the Wyss Center   “The Executive Board of the…

Scientist at the Universities of Geneva and Lausanne, Switzerland, designed a framework to analyse gene regulation, and offer a model…

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today announces the appointment of Dr Eric Yuen to its Board of Directors.

The Bern-Lausanne-Geneva region has been ranked #22 worldwide in this year’s edition of the Global Startup Ecosystem Report   Not only…

The SICHH and the HBP unite to further research on Alzheimer’s disease and dementia.   The SICHH welcomes the HBP…

Watch Deep Cube‘s video and learn more about one the canton of Vaud’s striving startups!        

By deciphering the genetic programmes of neurons of the cerebral cortex, Swiss and Belgian researchers unravel the mechanisms controlling the…

Avatarion : Robots in healthcare   The Digital Health Connect will take place on 7 June in Sierre in the…